BioCryst Pharmaceuticals Down Over 10%, on Track for Lowest Close Since June 2024 -- Data Talk

Dow Jones
2025/10/15

BioCryst Pharmaceuticals, Inc. $(BCRX)$ is currently at $6.33, down $0.71 or 10.09%

 

--Would be lowest close since June 28, 2024, when it closed at $6.18

--On pace for largest percent decrease since Nov. 4, 2024, when it fell 12.81%

--Currently down nine of the past 10 days

--Currently down four consecutive days; down 13.05% over this period

--Longest losing streak since Oct. 7, 2025, when it fell for five straight trading days

--Worst four-day stretch since the four days ending Nov. 15, 2024, when it fell 14.16%

--Down 16.6% month-to-date

--Down 15.82% year-to-date; on pace for worst year since 2023, when it fell 47.82%

--Down 80.89% from its all-time closing high of $33.12 on Aug. 25, 2000

--Down 15.37% from 52 weeks ago (Oct. 15, 2024), when it closed at $7.48

--Down 43.43% from its 52-week closing high of $11.19 on June 3, 2025

--Would be a new 52-week closing low

--Traded as low as $6.00; lowest intraday level since June 26, 2024, when it hit $6.00

--Down 14.77% at today's intraday low; largest intraday percent decrease since Nov. 4, 2024, when it fell as much as 18.8%

 

All data as of 3:21:15 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

October 14, 2025 15:25 ET (19:25 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10